RA CAPITAL MANAGEMENT, L.P. - Director, 10%+ Owner at Bicara Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
Director, 10%+ Owner
Issuer Symbol
BCAX on Nasdaq
All Insider Reports
All Insider Reports

RA CAPITAL MANAGEMENT, L.P. - trading volume in the past year for Bicara Therapeutics Inc.

Holdings reported by RA CAPITAL MANAGEMENT, L.P. for Bicara Therapeutics Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 4,603,418 $73,654,688 $16.00 26 Feb 2026 Indirect
Pre-Funded Warrant (Right to Buy) 2,200,000 $35,199,780 $16.00 26 Feb 2026 Indirect Common Stock
Stock Option (Right to Buy) 23,746 09 Jun 2025 Indirect Common Stock

Transactions reported by RA CAPITAL MANAGEMENT, L.P. for Bicara Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.